Literature DB >> 7724490

Surface denaturation at solid-void interface--a possible pathway by which opalescent particulates form during the storage of lyophilized tissue-type plasminogen activator at high temperatures.

C C Hsu1, H M Nguyen, D A Yeung, D A Brooks, G S Koe, T A Bewley, R Pearlman.   

Abstract

During protein lyophilization, it is common practice to complete the freezing step as fast as possible in order to avoid protein denaturation, as well as to obtain a final product of uniform quality. We report a contradictory observation made during lyophilization of recombinant tissue-type plasminogen activator (t-PA) formulated in arginine. Fast cooling during lyophilization resulted in a lyophilized product that yielded more opalescent particulates upon long term storage at 50 degrees C, under a 150 mTorr nitrogen seal gas environment. Fast cooling also resulted in a lyophilized cake with a large internal surface area. Studies on lyophilized products containing 1% (w/w) residual moisture and varying cake surface areas (0.22-1.78 m2/gm) revealed that all lyophilized cakes were in an amorphous state with similar glass transition temperatures (103-105 degrees C). However, during storage the rate of opalescent particulate formation in the lyophilized product (as determined by UV optical density measurement in the 360 to 340 nm range for the reconstituted solution) was proportional to the cake surface area. We suggest that this is a surface-related phenomenon in which the protein at the solid-void interface of the lyophilized cake denatures during storage at elevated temperatures. Irreversible denaturation at the ice-liquid interface during freezing in lyophilization is unlikely to occur, since repeated freezing/thawing did not show any adverse effect on the protein. Infrared spectroscopic analysis could not determine whether protein, upon lyophilization, at the solid-void interface would still be in a native form.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7724490     DOI: 10.1023/a:1016270103863

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  20 in total

1.  Malate dehydrogenase: a higher molecular weight form produced by freeze-thaw treatment of pig heart supernatant enzyme.

Authors:  D F Kimball; R G Wolfe
Journal:  Arch Biochem Biophys       Date:  1977-05       Impact factor: 4.013

2.  Biological standards: problems in large-scale production.

Authors:  P J Campbell
Journal:  Dev Biol Stand       Date:  1976-10

Review 3.  Freeze-drying: from empiricism to predictability. The significance of glass transitions.

Authors:  F Franks
Journal:  Dev Biol Stand       Date:  1992

4.  Determining the optimum residual moisture in lyophilized protein pharmaceuticals.

Authors:  C C Hsu; C A Ward; R Pearlman; H M Nguyen; D A Yeung; J G Curley
Journal:  Dev Biol Stand       Date:  1992

5.  Freezing denaturation of ovalbumin at acid pH.

Authors:  T Koseki; N Kitabatake; E Doi
Journal:  J Biochem       Date:  1990-03       Impact factor: 3.387

6.  Characterization studies of human tissue-type plasminogen activator produced by recombinant DNA technology.

Authors:  G A Vehar; M W Spellman; B A Keyt; C K Ferguson; R G Keck; R C Chloupek; R Harris; W F Bennett; S E Builder; W S Hancock
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1986

7.  Protein structure and freeze-drying: the effects of residual moisture and gases.

Authors:  D Greiff
Journal:  Cryobiology       Date:  1971-04       Impact factor: 2.487

8.  Measurement of glass transition temperatures of freeze-concentrated solutes by differential scanning calorimetry.

Authors:  L M Her; S L Nail
Journal:  Pharm Res       Date:  1994-01       Impact factor: 4.200

9.  A turbidimetric method to determine visual appearance of protein solutions.

Authors:  B M Eckhardt; J Q Oeswein; D A Yeung; T D Milby; T A Bewley
Journal:  J Pharm Sci Technol       Date:  1994 Mar-Apr

10.  Moisture-induced aggregation of lyophilized proteins in the solid state.

Authors:  W R Liu; R Langer; A M Klibanov
Journal:  Biotechnol Bioeng       Date:  1991-01-20       Impact factor: 4.530

View more
  7 in total

1.  Protein spray-freeze drying. Effect of atomization conditions on particle size and stability.

Authors:  H R Costantino; L Firouzabadian; K Hogeland; C Wu; C Beganski; K G Carrasquillo; M Córdova; K Griebenow; S E Zale; M A Tracy
Journal:  Pharm Res       Date:  2000-11       Impact factor: 4.200

2.  Synergistic effects of surfactants and sugars on lipoplex stability during freeze-drying and rehydration.

Authors:  Jinxiang Yu; Thomas J Anchordoquy
Journal:  J Pharm Sci       Date:  2009-09       Impact factor: 3.534

3.  Optimization of the fine particle fraction of a lyophilized lysozyme formulation for dry powder inhalation.

Authors:  Sarah Claus; Claudius Weiler; Joerg Schiewe; Wolfgang Friess
Journal:  Pharm Res       Date:  2013-04-09       Impact factor: 4.200

4.  Effects of Drying Process on an IgG1 Monoclonal Antibody Using Solid-State Hydrogen Deuterium Exchange with Mass Spectrometric Analysis (ssHDX-MS).

Authors:  Ehab M Moussa; Nathan E Wilson; Qi Tony Zhou; Satish K Singh; Sandeep Nema; Elizabeth M Topp
Journal:  Pharm Res       Date:  2018-01-03       Impact factor: 4.200

5.  Protein quantity on the air-solid interface determines degradation rates of human growth hormone in lyophilized samples.

Authors:  Yemin Xu; Pawel Grobelny; Alexander Von Allmen; Korben Knudson; Michael Pikal; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2014-03-12       Impact factor: 3.534

6.  Freeze-drying of plant tissue containing HBV surface antigen for the oral vaccine against hepatitis B.

Authors:  Marcin Czyż; Radosław Dembczyński; Roman Marecik; Justyna Wojas-Turek; Magdalena Milczarek; Elżbieta Pajtasz-Piasecka; Joanna Wietrzyk; Tomasz Pniewski
Journal:  Biomed Res Int       Date:  2014-10-12       Impact factor: 3.411

7.  Impact of Buffer, Protein Concentration and Sucrose Addition on the Aggregation and Particle Formation during Freezing and Thawing.

Authors:  Astrid Hauptmann; Katja Podgoršek; Drago Kuzman; Stanko Srčič; Georg Hoelzl; Thomas Loerting
Journal:  Pharm Res       Date:  2018-03-19       Impact factor: 4.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.